5-amino-1mq and cd38 inhibitor synergy nad+ SLC25A51 decouples the mitochondrial NAD+/NADH ratio to control proliferation of AML cells: Cell Metabolism Biological Functions and Therapeutic Potential
Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers NAD+ metabolism and its roles in cellular processes during ageing PMC New Insights on Muscle Strength: The Role of Inhibiting an Enzyme that Hinders NAD+ Synthesis Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS driven AML: Cell Metabolism Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect
Pay in 4 interest-free payments of $5.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





